| Variable | n (%) |
| Age (y) | |
| Median (range) | 75 (31 - 97) |
| Gender | |
| Male | 106 (54) |
| Female | 90 (46) |
| PS | |
| 0/1/2/3/4 | 3/32/81/62/18 |
| Primary site | |
| Colorectum | 49 (25) |
| Lung | 37 (19) |
| Stomach | 18 (9) |
| Pancreas | 17 (9) |
| Liver | 14 (7) |
| Breast | 13 (7) |
| Kidney | 8 (4) |
| Bile duct | 7 (4) |
| Prostate | 6 (3) |
| Esophagus | 5 (3) |
| Other | 22 (11) |
| Cancer status | |
| Metastatic | 111 (56) |
| Recurrence | 43 (22) |
| Inoperable | 42 (21) |
| No. of lesions | |
| 0 - 4 | 65 (33) |
| ≥5 | 131 (67) |
| Histology | |
| Adenocarcinoma | 103 (53) |
| Squamous cell carcinoma | 14 (7) |
| Hepatocellular carcinoma | 12 (6) |
| Small cell carcinoma | 5 (3) |
| Renal cell carcinoma | 5 (3) |
| Transitional cell carcinoma | 4 (2) |
| Other | 9 (5) |
| Unknown pathology | 44 (22) |